Sentara Infusion Services recalls DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c) 630MG IN NS 31.5ML used with a home pump; antibio
Recalled February 22, 2023 · FDA recall D-0286-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
17 bags
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML syringe(c) 630MG IN NS 31.5ML used with a home pump; antibiotic, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →